Literature DB >> 17823138

Erythropoietin use in critically ill patients: forest and trees.

Howard L Corwin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17823138      PMCID： PMC1976639          DOI： 10.1503/cmaj.071150

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  14 in total

1.  Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.

Authors:  Michael Silver; Michael J Corwin; Andrea Bazan; Andrew Gettinger; Christopher Enny; Howard L Corwin
Journal:  Crit Care Med       Date:  2006-09       Impact factor: 7.598

2.  Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

Authors:  Brian Leyland-Jones; Vladimir Semiglazov; Marek Pawlicki; Tadeusz Pienkowski; Sergei Tjulandin; George Manikhas; Antoly Makhson; Anton Roth; David Dodwell; Jose Baselga; Mikhail Biakhov; Konstantinas Valuckas; Edouard Voznyi; Xiangyang Liu; Els Vercammen
Journal:  J Clin Oncol       Date:  2005-08-08       Impact factor: 44.544

3.  Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.

Authors:  H L Corwin; A Gettinger; R M Rodriguez; R G Pearl; K D Gubler; C Enny; T Colton; M J Corwin
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

Review 4.  New avenues of exploration for erythropoietin.

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong
Journal:  JAMA       Date:  2005-01-05       Impact factor: 56.272

Review 5.  Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.

Authors:  Julia Bohlius; Jayne Wilson; Jerome Seidenfeld; Margaret Piper; Guido Schwarzer; Josie Sandercock; Sven Trelle; Olaf Weingart; Sue Bayliss; Benjamin Djulbegovic; Charles L Bennett; Simon Langensiepen; Chris Hyde; Andreas Engert
Journal:  J Natl Cancer Inst       Date:  2006-05-17       Impact factor: 13.506

6.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

7.  Anemia of the critically ill: "acute" anemia of chronic disease.

Authors:  H L Corwin; S B Krantz
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

8.  Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.

Authors:  Ryan Zarychanski; Alexis F Turgeon; Lauralyn McIntyre; Dean A Fergusson
Journal:  CMAJ       Date:  2007-09-05       Impact factor: 8.262

9.  Efficacy and safety of epoetin alfa in critically ill patients.

Authors:  Howard L Corwin; Andrew Gettinger; Timothy C Fabian; Addison May; Ronald G Pearl; Stephen Heard; Robert An; Peter J Bowers; Paul Burton; Mark A Klausner; Michael J Corwin
Journal:  N Engl J Med       Date:  2007-09-06       Impact factor: 91.245

10.  The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

Authors:  Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598
View more
  4 in total

1.  Erythropoietin reduces acute lung injury and multiple organ failure/dysfunction associated to a scald-burn inflammatory injury in the rat.

Authors:  Joao Rocha; Maria Eduardo-Figueira; Andreia Barateiro; Adelaide Fernandes; Dora Brites; Rui Pinto; Marisa Freitas; Eduarda Fernandes; Helder Mota-Filipe; Bruno Sepodes
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

2.  The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis.

Authors:  Anna Wärme; Henrik Hadimeri; Salmir Nasic; Bernd Stegmayr
Journal:  BMC Nephrol       Date:  2021-01-18       Impact factor: 2.388

Review 3.  Anemia and blood transfusions in critically ill patients.

Authors:  M Kamran Athar; Nitin Puri; David R Gerber
Journal:  J Blood Transfus       Date:  2012-10-04

Review 4.  The role of erythropoietin as an inhibitor of tissue ischemia.

Authors:  Nikolaos Paschos; Marios G Lykissas; Alexandros E Beris
Journal:  Int J Biol Sci       Date:  2008-06-10       Impact factor: 6.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.